Coherus Oncology (CHRS) EPS (Basic) (2013 - 2026)
Coherus Oncology (CHRS) reported EPS (Basic) of -$0.01 for Q1 2026, up 87.11% on a YoY basis from -$0.01 in Q1 2025, and down 113.74% sequentially from $0.07 in Q4 2025.
Coherus Oncology (CHRS) EPS (Basic) (2013 - 2026) Analysis & Trends
Coherus Oncology (CHRS) has 14 years of EPS (Basic) data on file, last reported at -$0.01 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 87.11% year-over-year to -$0.01; the trailing twelve-month figure through Mar 2026 stood at $2.63 (up 369.01% YoY), and the FY2025 full-year result was $3.0, up 40.79% from the prior year.
- EPS (Basic) eased to -$0.01 in Q1 2026, from $0.07 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $2.95 in Q2 2025 to a low of -$1.24 in Q1 2022.
- A 5-year average of -$0.08 and a median of -$0.08 in 2025 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) sank 128.56% in 2022 and jumped 708.29% in 2025, its largest moves.
- Tracing CHRS's EPS (Basic) over 5 years: stood at -$0.76 in 2022, then decreased by 11.55% to -$0.85 in 2023, then soared by 95.25% to -$0.04 in 2024, then jumped by 284.91% to $0.07 in 2025, then tumbled by 113.74% to -$0.01 in 2026.
- Business Quant data shows CHRS's EPS (Basic) at -$0.01 in Q1 2026, $0.07 in Q4 2025, and $0.08 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Coherus Oncology | 194.37 Mn | 27.32 Mn | 8.50 Mn | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01 |
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 2.95 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | -0.04 |
| Sep 30, 2024 | 0.32 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 1.52 |
| Dec 31, 2023 | -0.85 |
| Sep 30, 2023 | -0.41 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | -0.96 |
| Dec 31, 2022 | -0.76 |
| Sep 30, 2022 | -1.11 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -1.24 |
| Dec 31, 2021 | -0.61 |
| Sep 30, 2021 | -0.49 |
| Jun 30, 2021 | -0.40 |